Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Imperium honours top performers
2012-08-17

Attending Imperium Residence’s academic evening was, from left: Dr Scarpa Schoeman, Residence Head of Veritas, Dr Mpho Moagi-Jama, Residence Head of Imperium; Michael van Niekerk, Primarius of Imperium; Monique Visser; Mr Pura Mgolombane, Assistant Dean of Student Life and Leadership; and Monique Janse van Rensburg, a former primaria of Imperium.
Photo: Amanda Tongha
17 August 2012

 

The city residence Imperium, previously known as Medix, honoured its academic performers during the residence’s annual academic evening, which was held on Thursday 16 August 2012. Certificates were handed out to the residence’s top first-year and senior students.

A bursary of R10 000 was also handed over to a student. The money was collected by the students themselves. Monique Visser, a first-year medical student, who was among the top ten matriculants in the Western Cape in 2011, received the bursary. Monique was also named the second best student in her year group.

Michael van Niekerk, Primarius of Imperium and the best third-year student, praised Monique for her hard work and said it was good to give back to students.

Dr. Mpho Moagi-Jama, the residence head of Imperium, praised her students and said they must continue being outstanding.

Imperium, which underwent a name change recently, is open to male and female students in all fields of study.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept